High Cholesterol

Clinical Trial Finder

Many patients with high cholesterol are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Association of Air Quality and Myocardial Infarction

Condition:   Acute Myocardial Infarction
Intervention:   Other: air pollution
Sponsor:   Medical University of Graz
Active, not recruiting - verified August 2016

Neurothrombectomy France

Condition:   Cerebral Artery Occlusion
Intervention:  
Sponsor:   Nantes University Hospital
Completed - verified August 2016

A Study in Subjects With Type 2 Diabetes Mellitus With Hypercholesterolemia/Mixed Dyslipidemia

Conditions:   Hypercholesterolemia;   Mixed Dyslipidemia;   Type 2 Diabetes
Interventions:   Biological: Evolocumab;   Other: Placebo to Evolocumab
Sponsor:   Amgen
Recruiting - verified August 2016

Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia

Condition:   Hypercholesterolemia
Interventions:   Drug: alirocumab SAR236553 (REGN727);   Drug: placebo for alirocumab;   Drug: ezetimibe;   Drug: placebo for ezetimibe;   Drug: atorvastatin;   Drug: rosuvastatin;   Drug: simvastatin
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Recruiting - verified August 2016

Hyperglycemia and Mitochondrial Function in The Endothelium of Humans

Conditions:   Diabetes;   Hyperglycemia
Intervention:   Other: 75 g glucose solution
Sponsor:   Medical College of Wisconsin
Not yet recruiting - verified August 2016

Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase

Conditions:   Healthy;   Hypercholesterolemia
Interventions:   Biological: Cohort 1: bococizumab 150 mg + rHuPH20;   Biological: Cohort 2: bococizumab 300 mg;   Biological: Cohort 3: bococizumab 300 mg + rHuPH20;   Biological: Cohort 5: bococizumab 450 mg + rHuPH20;   Biological: Cohort 4: bococizumab 300 mg + rHuPH20
Sponsors:   Pfizer;   Halozyme Therapeutics
Terminated - verified August 2016

Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

Condition:   Coronary Artery Disease, Hypercholesterolemia, Hypertension
Intervention:   Other: No intervention
Sponsor:   Pfizer
Not yet recruiting - verified August 2016

Validating the "Foods for Health" Portfolio of Functional Food Products

Condition:   Hypercholesterolemia
Interventions:   Other: Portfolio of functional foods;   Other: Control foods
Sponsors:   University of Manitoba;   Manitoba Agri-Health Research Network;   Manitoba Jobs and the Economy;   TM Therapeutics;   StepOne Canada
Recruiting - verified August 2016

A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia

Condition:   Hypercholesterolemia
Interventions:   Drug: Evacetrapib;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Terminated - verified August 2016

A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia

Condition:   Hypercholesterolemia
Interventions:   Drug: Evacetrapib;   Drug: Ezetimibe;   Drug: Atorvastatin;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Terminated - verified August 2016

Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab

Condition:   Hypercholesterolemia
Intervention:   Biological: Evolocumab
Sponsor:   Amgen
Active, not recruiting - verified August 2016

Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)

Conditions:   Psoriasis;   Cardiovascular Disease
Interventions:   Drug: Ustekinumab;   Drug: Placebo
Sponsors:   University of Pennsylvania;   Janssen Scientific Affairs, LLC
Recruiting - verified August 2016

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Condition:   Hyperlipidemia
Interventions:   Drug: Bococizumab (PF-04950615; RN316);   Other: Placebo
Sponsor:   Pfizer
Completed - verified August 2016

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Conditions:   Psoriasis;   Cardiovascular Disease
Interventions:   Drug: Adalimumab (Humira);   Drug: Placebo Injection;   Other: NB-UVB phototherapy
Sponsor:   University of Pennsylvania
Active, not recruiting - verified August 2016

Functional and Cognitive Impairment in Advanced Kidney Disease

Condition:   Kidney Insufficiency, Chronic
Intervention:  
Sponsor:   VA Office of Research and Development
Active, not recruiting - verified August 2016